GlassScriptPhysician profile
Omkar Baxi
NPI 1811317845
$10,886.63
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10K · 2021: $286 · 2022: $119.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,199.61 | 2020 | |
| Daiichi Sankyo INC. | $242.54 | 2021 | |
| Axogen | $145.59 | 2020-2021 | |
| Amgen INC. | $118.80 | 2022 | |
| Pacira Therapeutics, INC. | $98.00 | 2020 | |
| Trice Medical, INC. | $50.00 | 2020 | |
| Skeletal Dynamics INC | $32.09 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omkar Baxi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.